Report on China’s Veterinary Biologics Industry Investment

This report will provide a detailed analysis of the above questions and, on the basis of an exposition about the status quo of China’s veterinary biologics industry in 2011, make an in-depth analysis of the development environment, enterprises structure and scale, as well as the circulation and marketing of China’s veterinary biologics industry. Besides, the report will also make a detailed and objective analysis of the development trend of China’s veterinary biologics industry, aiming to be of help to the scientific judgment of the investment value of China’s veterinary biologics industry.

1. Development Course and Direction of China’s Veterinary Biologics Industry
1.1 China’s Veterinary Biological Industry Development Course
1.2 Position and Market Share of Biological Products in China’s Veterinary Heath-care Industry
1.3 Comparison between Global and China’s Veterinary Biologics Industry
1.4 China’s Veterinary Biologics Industry Development Direction
2 Policy Environment of China’s Veterinary Biologics Industry
2.1 Production Policy for China’s Veterinary Biologic Industry
2.2 Planning of China’s Veterinary Biologic Industry
2.3 Impact of Compulsory Immunization Policy on China’s Veterinary Biologic Industry
2.4 Trade Policy for China’s Veterinary Biologic Industry
2.5 Circulation Policy for China’s Veterinary Biologic Industry
2.6 Impact of China’s Veterinary Biologic Industry Policy on Future Industry Development
3 Market Scale and Development Trend of China’s Veterinary Biologics Industry
3.1 Scale of China’s Veterinary Biological Products by Types
3.1.1Market Scale of Compulsory Immunization Vaccine
3.1.2 Market Scale of Domestic-produced Conventional Vaccine
3.1.3Market Scale of Imported Conventional Vaccine
3.2 China’s Hog Biological Products Market Scale and Estimation
3.2.1 Occurrence of Hog Diseases and Development Trend in China
3.2.2 Status quo of China’s Hog Biological Products Utility and Market Demand
3.2.3 Major Products and Market Share of China’s Hog Biological Products
3.2.4 Estimation of China’s Hog Biological Products Market Growth
3.3 China’s Poultry Biological Products Market Scale and Estimation
3.3.1 Occurrence of Poultry Diseases and Development Trend in China
3.3.2 Status quo of China’s Poultry Biological Products Utility and Market Demand
3.3.3 Major Products and Market Share of China’s Poultry Biological Products
3.3.4Estimation of China’s Poultry Biological Products Market Growth
3.4 China’s Ruminant Veterinary Biological Products Market Scale and Estimation
3.4.1 Occurrence of Ruminant Animal Diseases and Development Trend in China
3.4.2 Status quo of China’s Ruminant Veterinary Biological Products Utility and Market Demand
3.4.3 Major Products and Market Share of China’s Ruminant Veterinary Biological Products
3.4.4Estimation of China’s Ruminant Veterinary Biological Products Market Growth
3.5 China’s Aquatic Veterinary Biological Products Market Scale and Estimation
3.5.1 Occurrence of Aquatic Animal Diseases and Development Trend in China
3.5.2 Status quo of China’s Aquatic Veterinary Biological Products Utility and Market Demand
3.5.3 Major Products and Market Share of China’s Aquatic Veterinary Biological Products
3.5.4Estimation of China’s Aquatic Veterinary Biological Products Market Growth
3.6 China’s Pet Veterinary Biological Products Market Scale and Estimation
3.6.1 Occurrence of Pet Animal Diseases and Development Trend in China
3.6.2 Status quo of China’s Pet Veterinary Biological Products Utility and Market Demand
3.6.3 Major Products and Market Share of China’s Pet Veterinary Biological Products
4 Analysis of China’s Veterinary Biologics Industry Chain
4.1 Research and Development (R&D)
4.1.1 Major Research Institutions of Veterinary Biological Products in China
4.1.2 Technical R&D Capability of China’s Veterinary Biologics Industry
4.1.3 Mechanism of Technical R&D Investment in Veterinary Biologics Industry in China
4.2 Production
4.2.1 Output Capacity and Output Value of China’s Veterinary Biological Products Market
4.2.2 Production Profit of China’s Veterinary Biologics Industry
4.2.3 Price Trend of China’s Major Veterinary Biological Products
4.2.3.1 Price Trend of China’s Major Hog Veterinary Biological Products
4.2.3.2 Price Trend of China’s Major Poultry Veterinary Biological Products
4.2.4 Structure and Locations of China’s Major Veterinary Biologics Enterprises
4.2.5 Concentration of China’s Veterinary Biological Products Market
4.3 Circulation
4.3.1Circulation Pattern of China’s Veterinary Biological Products
4.3.2 Analysis of Marketing Channels of China’s Veterinary Biological Products
4.3.3 Analysis of Profit Distribution in China’s Veterinary Biological Products Circulation
4.3.3.1 The Marketing Pattern and Cost Structure of the Level 1 Distributor
4.3.3.2 The Marketing Pattern and Cost Structure of Level 2 Distributor
4.3.3.3 The Marketing Pattern and Cost Structure of Direct Distributor
4.3.3.4 Analysis of Profit Distribution among Distributors at Different Levels
4.3.4 Major Marketing Patterns and Customer Strategies of China’s Veterinary Biological Products
4.3.5 The Impact of GSP on the Circulation and Marketing of China’s Veterinary Biological Products
4.4 Overall Evaluation of China’s Veterinary Biologics Industry Chain
5 Analysis of Investment Opportunities and Directions in China’s Veterinary Biologics Industry
5.1 Analysis of Investment Opportunities and Directions in China’s Hog Veterinary Biological Products
5.2 Analysis of Investment Opportunities and Directions in China’s Poultry Veterinary Biological Products
5.3 Analysis of Investment Opportunities and Directions in China’s Ruminant Veterinary Biological Products
5.4 Analysis of Investment Opportunities and Direction sin China’s Aquatic Veterinary Biological Products
5.5 Analysis of Investment Opportunities and Directions in China’s Pet Veterinary Biological Products
5.6 Analysis of Investment Opportunities and Directions in China’s Other Veterinary Biological Products
6 Analysis of the Investment Risks in China’s Veterinary Biologics Industry
6.1 Risk of Low R&D Capability
6.2 Risk of Intellectual Property Protection
6.3 Risk of Products Quality Control
6.4 Risk of Severe Animal Diseases
6.5 Risk of Shortage of Service Capability and Human Resources
6.6 Risk of Market Competition
7 Analysis of Key Enterprises in China’s Veterinary Biologics Industry
7.1 Analysis of Listed Enterprises
7.1.1 CAHIC (China Animal Husbandry Industry Co., Ltd)
7.1.1.1 Enterprise Profile
7.1.1.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
7.1.1.3 Sales Revenue, Profit and Trend of Share Prices
7.1.1.4 Constitution of Major Business/ Products/Service
7.1.2 TCSW
7.1.2.1 Enterprise Profile
7.1.2.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
7.1.2.3 Sales Revenue, Profit and Trend of Share Prices
7.1.2.4 Sales Revenue, Profit and Trend of Share Prices
7.1.3 Inner Mongolia Jinyu Group Co., Ltd.
7.1.3.1 Enterprise Profile
7.1.3.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
7.1.3.3 Sales Revenue, Profit and Trend of Share Prices
7.1.3.4 Constitution of Major Business/ Products/Service
7.1.4 Ringpu Biology
7.1.4.1 Enterprise Profile
7.1.4.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
7.1.4.3 Sales Revenue, Profit and Trend of Share Prices
7.1.4.4 Constitution of Major Business/ Products/Service
7.2 Analysis of Enterprises not listed
7.2.1 Analysis of China’s Top 10 Hog Veterinary Biological Products Enterprises
7.2.2 Analysis of China’s Top 10 Poultry Veterinary Biological Products Enterprises
7.3 Selection and Analysis of China’s Other Veterinary Biological Products Enterprises
8 Major Foreign-Invested Enterprises and Analysis of Their Market Competitiveness
8.1 Pfizer/ Fort Dodge
8.1.1 Profile of China Branch
8.1.2 Sales Revenue
8.1.3 Major Products and Market Share
8.1.4 Analysis of Its Competitiveness in Chinese Market
8.2 Boehringer Ingelheim
8.2.1 Profile of China Branch
8.2.2 Sales Revenue
8.2.3 Major Products and Market Share
8.2.4 Analysis of Its Competitiveness in Chinese Market
8.3 Merial
8.3.1 Profile of China Branch
8.3.2 Sales Revenue
8.3.3 Major Products and Market Share
8.3.4 Analysis of Its Competitiveness in Chinese Market
8.4 Bayer
8.4.1 Profile of China Branch
8.4.2 Sales Revenue
8.4.3 Major Products and Market Share
8.4.4 Analysis of Its Competitiveness in Chinese Market
8.5 Novartis
8.5.1 Profile of China Branch
8.5.2 Sales Revenue
8.5.3 Major Products and Market Share
8.5.4Analysis of Its Competitiveness in Chinese Market
8.6 Hipra
8.6.1 Profile of China Branch
8.6.2 Sales Revenue
8.6.3 Major Products and Market Share
8.6.4 Analysis of Its Competitiveness in Chinese Market
8.7 Intervet / Schering-Plough
8.7.1 Profile of China Branch
8.7.2 Sales Revenue
8.7.3 Major Products and Market Share
8.7.4 Analysis of Its Competitiveness in Chinese Market
8.8 Lohmann
8.8.1 Profile of China Branch
8.8.2 Sales Revenue
8.8.3 Major Products and Market Share
8.8.4 Analysis of Its Competitiveness in Chinese Market
8.9 U.S. PeproTech
8.9.1 Profile of China Branch
8.9.2 Sales Revenue
8.9.3 Major Products and Market Share
8.9.4 Analysis of Its Competitiveness in Chinese Market
8.10 Italy Ascor Chimici Srl
8.10.1 Profile of China Branch
8.10.2 Sales Revenue
8.10.3 Major Products and Market Share
8.10.4 Analysis of Its Competitiveness in Chinese Market
Appendix:Name List of China’s Veterinary Biological Products Enterprises
 
Figures & Tables
Figure 1.1 Proportion of China’s Domestic Biological Products in Domestic Veterinary Health-Care Industry 2005-2011
Figure 1.2 Global Veterinary Health-Care Products Sales Revenue  2004-2011
Figure 1.3 Global Veterinary Biological Products Sales Revenue  2008-2011
Figure 3.1 China's Veterinary Biological Products by Types in 2011
Figure 3.2 China's Imported Veterinary Biological Products Amount Growth Trend in 2009-2011
Figure 3.3 Source Structure of China's Imported Veterinary Biological Products in 2011
Figure 3.4 Import Provinces of China's Veterinary Biological Products in 2011
Figure 3.5 Customs for China's Imported Veterinary Biological Products in 2011
Figure 3.6 Occurrence of Hog Diseases in 2011
Figure 3.7 Major Products and Market Share of China’s Hog Biological Products in 2011
Figure 3.8 China’s Hog Biological Products Market Scale and Growth Estimation in 2009-2016
Figure 3.9 Occurrence of Major Poultry Diseases in China in 2011
Figure 3.10 Major Products and Market Share of China’s Poultry Biological Products
Figure 3.11 China’s Poultry Biological Products Market Scale and Growth Estimation in 2009-2016
Figure 3.12 Occurrence of Major Cattle Diseases in 2011
Figure 3.13 Occurrence of Major Sheep Diseases in 2011
Figure 3.14 Major Products and Market Share of China’s Cattle, Sheep and Horse Veterinary Biological Products
Figure 3.15 China’s Ruminant Veterinary Biological Products Market Scale and Growth Estimation in 2009-2016
Figure 3.16 China’s Aquatic Veterinary Biological Products Market Scale and Growth Estimation in 2009-2016
Figure 3.17 China’s Pet Veterinary Biological Products Market Scale and Growth Estimation in 2009-2016
Figure 4.1 Mechanism of Technical R&D Investment in Veterinary Biologics Industry in China
Table 4.1 Proportion of R&D Investment in Industry Sales in Different Countries and Regions
Figure 4.2 R&D Personnel scale of veterinary biologics enterprise
Table 4.2 Output capacity, volume and utilization of china’s veterinary biological products by types in 2010
Figure 4.3 Comparison gross profit of veterinary biologics enterprises of different scales
Figure 4.4 Average Bidden Price of Hog Vaccines of an Enterprise in 2008-2012
Figure 4.5 Average Bidden Price of Avian Influenza Vaccines of an Enterprise in 2008-2012
Figure 4.6 Structure and Locations of China’s Major Veterinary Biologics Enterprises
Figure 4.7 Number of Enterprises of China’s Major Veterinary Biologics Enterprises (According to Sales)
Figure 4.8 Market Share of China's Top 10 Veterinary Biologics Enterprises
Figure 4.9 Terminal marketing channels of China's veterinary biological products
Figure 4.10 Cost Structure of the Level 1 Distributor of Veterinary Biological Products
Figure 4.11 Cost Structure of Level 2 Distributor of Veterinary Biological Products
Figure 4.12 Cost structure of level I distributor of veterinary biological products
Figure 5.1，Standardized Large-Scale Hog Farming in China in 2001-2011
Figure 5.2，China’s Chicken Meat Consumption and Changes of Per Capita Chicken Meat Consumption, 2000-2015
Figure 5.3，China’s Broiler Chicken Farming Scale Structure in 2000-2011
Figure 5.4，Standardization of China’s Large-Scale Broiler Chicken Farming in 2001-2011
Figure 7.1 Stock Price Graph of CAHIC in Recent Three Years (Unit: Yuan)
Figure 7.2 Proportion of CAHIC's Veterinary Biologics Products in Main Business
Figure 7.3 TCSW's Trend of Share Prices in Recent Three Years (Unit: Yuan)
Figure 7.4 Proportion of Veterinary Biological Products in TCSW's Major Business in 2011
FIgure7.5 Jinyu's Trend of Share Prices in Recent Three Years (Unit: Yuan)
Figure 7.6 Proportion of veterinary biological products in Jinyu's major business in 2011
Figure 7.7 Ringpu's trend of share prices in recent two years (unit: Yuan)
Figure 7.8，Proportion of Veterinary Biological Products in Ringpu's Major Business in 2011
Figure 7.9 Market Shares of China’s Top 10 Hog Veterinary Biological Products Enterprises in 2011
Figure 7.10 Market Shares of China's Top 10 Poultry Veterinary Biological Products Enterprises in 2011